✦ LIBER ✦

A Phase III Double-Blind, Placebo-Controlled Trial of Every Other Day Dosing of Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness

✍ Scribed by N. Slatkin; S. Karver; J. Thomas; B. Chamberlain; G. Austin–Cooney; C. Watt; J. Winston; K. Cross; D. McGrew; N. Stambler; R.J. Israel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous Methylnaltrexone for the Tr

✍ Russell K. Portenoy; Jay Thomas; Michele L. Moehl Boatwright; Diep Tran; Frank L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 223 KB

A phase 2, double-blind, randomized, pla

✍ Webster, Lynn; Dhar, Sunita; Eldon, Michael; Masuoka, Lorianne; Lappalainen, Jaa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Aprepitant triple therapy for the preven

✍ Hu, Zhihuang; Cheng, Ying; Zhang, Hongyu; Zhou, Caicun; Han, Baohui; Zhang, Yipi 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 347 KB

Famotidine for the prevention of peptic

✍ Ali S Taha; Caroline McCloskey; Rakesh Prasad; Vladimir Bezlyak 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 155 KB

906 A Phase 3, Randomized, Double-Blind,

✍ Byron L. Cryer; Seymour Katz; Ricardo Vallejo; Charles B. Scott; Taryn R. Joswic 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A double blind, randomised, placebo cont

✍ Samit Ghosh; Ged Dempsey; Rachel Skelly; Richard J. Shaw; Simon N. Rogers; Derek 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 170 KB